Latest News
Insurance company Progressive (NYSE:PGR) will be reporting results this Wednesday before market hours. Here’s what you need to know. Progressive met analysts...
Via StockStory · October 12, 2026
Financial services giant Bank of America (NYSE:BAC) will be announcing earnings results this Wednesday before market open. Here’s what to expect. Bank of Ame...
Via StockStory · October 12, 2026
Regional banking company Home Bancshares (NYSE:HOMB) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. Home Ba...
Via StockStory · October 12, 2026
Financial services giant State Street (NYSE:STT) will be reporting earnings this Wednesday before the bell. Here’s what to look for. State Street beat analys...
Via StockStory · October 12, 2026
Global financial services firm Morgan Stanley (NYSE:MS) will be reporting earnings this Wednesday morning. Here’s what to look for. Morgan Stanley beat analy...
Via StockStory · October 12, 2026
Amazon trades at a premium valuation despite stronger free cash flow, while Alibaba offers a cheaper entry point but faces regulatory headwinds in China.
Via The Motley Fool · October 12, 2026
Quarterly revenue at the AI chip leader is over five times what it was right before its big customer's first in-house chip debuted.
Via The Motley Fool · October 12, 2026
One company is profitable and raising its outlook. The other just hit a free cash flow milestone but is still working through a significant restructuring with heavy losses.
Via The Motley Fool · October 12, 2026
One platform is seeing AI spending translate directly into surging cloud revenue. The other is growing fast but navigating rising costs and a missed earnings quarter.
Via The Motley Fool · October 12, 2026
Carlos Henrique Villela Pedras doubled his direct stake, signaling confidence in the Brazilian bank despite modest recent returns.
Via The Motley Fool · October 12, 2026
Micron just increased its stock buyback authorization to $35.16 billion.
Via The Motley Fool · October 12, 2026
A researcher tracking the company raised its price target.
Via The Motley Fool · October 12, 2026
AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.
Via The Motley Fool · October 12, 2026
Anduril is stealthily becoming a key producer of U.S. Navy submarines -- and also not so stealthily.
Via The Motley Fool · October 12, 2026
Investors weren't cheered by a major change in the company's leadership.
Via The Motley Fool · October 12, 2026
Paulo Roberto Simoes Da Cunha expanded his direct stake by 22%, bringing total holdings to ~265,000 shares at $17.98 per share.
Via The Motley Fool · October 12, 2026
Don't let shortsighted sellers distract you from this coin's real value.
Via The Motley Fool · October 12, 2026
An analyst made a significant price target cut.
Via The Motley Fool · October 12, 2026
One trades at half the earnings multiple of the other, but profitability and risk profiles tell starkly different stories.
Via The Motley Fool · October 12, 2026
The manufacturing leader is driving growth across multiple dimensions.
Via The Motley Fool · October 12, 2026
Don't get caught off guard by the impact of a higher income.
Via The Motley Fool · October 12, 2026
These companies have a long history of dividend growth.
Via The Motley Fool · October 12, 2026
Insider buying increased direct holdings to 264,605 shares, a 22% boost to prior equity exposure. The preferred stock traded at $17.98 per share during the acquisition, well above the $3.43 market close for common shares that same day.
Via The Motley Fool · October 12, 2026
The Ark Invest CEO has a lofty forecast for SpaceX.
Via The Motley Fool · October 12, 2026
Archer pursues Boeing partnerships to scale manufacturing, while Joby leverages early revenue from its Blade acquisition, but both burn cash at an alarming rate.
Via The Motley Fool · October 12, 2026
